Severe impact of hemolysis on stability of phenolic compounds

Bioanalysis

Volumn 5, Issue 12, 2013, Pages 1491-1499

  Bérubé, Eugénie Raphaëlle ^a   Lacasse, Marie Christine ^a   Furtado, Milton ^a   Garofolo, Fabio ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; ETODOLAC; FERRIC ION; FERROUS ION; KETOPROFEN; METHEMOGLOBIN; MORPHINE; PHENOL DERIVATIVE; RALOXIFENE;

DIMERIZATION; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG ISOLATION; DRUG STABILITY; DRUG STRUCTURE; HEMOLYSIS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; PH; REVIEW; SOLID PHASE EXTRACTION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CODEINE; DRUG STABILITY; HEMOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; METHEMOGLOBIN; MORPHINE; MORPHINE DERIVATIVES; PHENOLS; TANDEM MASS SPECTROMETRY;

EID: 84879638597     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.109     Document Type: Review

References (24)

1. Savoie N Garofolo F van Amsterdam P et al. 2009 White paper on recent issues in regulated bioanalysis from the third calibration and validation group workshop Bioanalysis 2 1 53-68 (2010).
2. Savoie N Garofolo F van Amsterdam P et al. 2010 White Paper on recent issues in regulated bioanalysis and global harmonization of bioanalytical guidance Bioanalysis 2 12 1945-1960 (2010).
3. Garofolo F, RocciML, Dumont I et al. 2011 White Paper on recent issues in bioanalysis and regulatory findings from audits and inspections.Bioanalysis 3(18), 2081-2096 (2011).
4. DeSilva B, Garofolo F, Rocci M et al. 2012 White Paper on recent issues in bioanalysis and alignment of multiple guidelines. Bioanalysis 4(18), 2213-2226 (2012).
5. Lippi G, Blanckaert N, Bonini P et al.Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin. Chem. Lab. Med. 46(6), 764-772 (2008).
6. Hooser B, McCarthy J, Wilson C, Harms J, Stevenson G, Everson R. Effects of storage conditions and hemolysis on vitamin E concentrations in porcine serum and liver. J. Vet. Diagn. Invest. 12, 365-368 (2000).
7. Hughes N, Bajaj N, Fan J, Wong E. Assessing the matrix effects on hemolyzed samples in bioanalysis. Bioanalysis 1(6), 1057-1066 (2009).
8. Taillon M-P, Latour S, Bergeron M, Mess J-N, Furtado M, Garofolo F. Impact of hemolysis on matrix effect, recovery and ionization in bioanalytical LC-MS/MS methods. Presented at: The 58th American Society for Mass Spectrometry Conference. Salt Lake City, UT, USA, 23-27 May 2010.
9. Bérubé E-R, Taillon M-P, Furtado M, Garofolo F. Impact of sample hemolysis on drug stability in regulated bioanalysis. Bioanalysis 3(18), 2097-2105 (2011).
10. Bérubé E-R, Furtado M, Garofolo F. Hemolysis effect on the processed reconstituted stability of morphine in different reconstitution solutions. Presented at: 59th American Society for Mass Spectrometry Conference. Denver, CO, USA, 5-9 June 2011.
11. Brown HC, McDaniel DH, Häfliger O. Dissociation constants. In:Determination of Organic Structures by Physical Methods (Volume 1) . Braude EA, Nachod FC (Eds). Academic Press, New York, NY, USA, 567-662 (1955).
12. Gawron O, Duggan M, Grelecki CJ. Manometric determination of dissociation constants of phenols. Anal. Chem. 24(6), 969-970 (1952).
13. Yeh SY, Lach J. Stability of morphine in aqueous solution III. Kinetics of morphine degradation in aqueous solution. J. Pharm. Sci. 50, 35-42 (1961).
14. Vermeire A, Remon JP. Stability and compatibility of morphine. Int. J. Pharm. 187, 17-51 (1999).
15. Davis JA, Greene RJ, Han S et al. Formation of raloxifene homo-dimer in CYP3A4, evidence for multi-substrate binding in a single catalytically competent P450 active site.Arch. Biochem. Biophys. 513(2), 110-118 (2011).
16. Liu X, Spolarics Z. Methemoglobin is a potent activator of endothelial cells by stimulating IL-6 and IL-8 production and E-selectin membrane expression. Am. J. Physiol. Cell Physiol. 285(5), C1036-C1046 (2003).
17. Palaniandavar M, Velusamy M, Mayilmurugan R. Iron(III) complexes of certain tetradentate phenolate ligands as functional models for catechol dioxygenases. J. Chem. Sci. 118(6), 601-610 (2006).
18. George P, LysterRLJ, Beetlestone J. The reaction of ferrimyoglobin with phenol. J. Biol. Chem. 236(12), 3246-3251 (1961).
19. Liu ZD, Hider RC. Design of clinically useful iron(III)-selective chelators. Med. Res. Rev. 22(1), 26-64 (2002).
20. Lauffer RB, Heistand RHII, Que L Jr. Dioxygenase model studies: reaction of oxygen with iron catecholates. J. Am. Chem. Soc. 103(13), 3947-3949 (1981).
21. Arai H, Bertlett BS, Chock PB, Stadtman ER. Effect of bicarbonate on iron-mediated oxidation of low-density lipoprotein. Proc. Natl Acad. Sci. USA 102(30), 10472-10477 (2005).
22. Nagy E, Jeney V, Yachie A et al. Oxidation of hemoglobin by lipid hydroperoxide associated with low-density lipoprotein (LDL) and increased cytotoxic effect by LDL oxidation in heme oxygenase-1 (HO-1) deficiency. Cell.Mol. Biol. 51(4), 377-385 (2005).
23. US FDA. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2001).
24. Tang D, Thomas E. Strategies for dealing with hemolyzed samples in regulated LC-MS/MS bioanalysis. Bioanalysis 4(22), 2715-2724 (2012).